- Four investors interested in Galenika have submitted the request for purchase of the information package in the procedure of collection of indicative bids for sale of that Belgrade-based pharmaceutical company - the Privatization Agency announced on Friday (February 19, 2010).
- The requests for purchase of the documentation have been submitted by "three renowned pharmaceutical companies and an international financial investor" - it is written in the statement.
Once the Privatization Agency determines whether these investors meet the qualification terms, the qualified interested companies will be able to submit their indicative bids prior to 3 PM on March 19, 2010.
Indicative bids must contain the most important terms under which the potential buyer is interested in buying Galenika - price, percentage of ownership, investments, social program.
- Upon the expiration of that deadline in March and consideration of the terms offered by all potential buyers, the Privatization Agency, the Ministry of Economy and Regional Development and the Government of Republic of Serbia will make the decision on possible announcement of public invitation for sale of Galenika, as well as on the terms under which such public call will be announced - it is written in the statement.
The Privatization Agency announced the public call for submission of indicative bids for takeover of Belgrade-based Galenika on December 14th, 2009, in daily newspapers Financial Times and Politika.
The aim of the pre-qualification tender is to provide an insight into the interests and profiles of potential investors.
All interested investors are invited to submit indicative bids for purchase of the majority share in total registered stock capital of Galenika that is owned by the state.
Non-binding bids were accepted from the investors who bought the information package, who were present in pharmaceutical industry in the previous five consecutive years and who registered over 100m EUR worth of income from the sale of pharmaceutical products in 2008.
Also, the financial investors who bought the information package and whose total assets under the management exceeded 250m EUR at the end of 2008 were able to submit the bids.
B92 discovered which companies bought the documentation?
As B92 learns, four companies that bought the documentation are: Alapis (Greece), Stada (Germany), U.S. Abot and investment fund OMNIA. However, people in the Privatization Agency did not want to either confirm or deny that information. They explained that it was decided that the names of potential buyers of Galenika should remain secret because one of the companies that had bought the tender documentation insisted on that.
According to B92, one of the potential buyers of Galenika that, as the people from the Privatization Agency explained, "was clear that it would not bid on the tender if it was published that it had bought the tender documentation", is German Stada, which is already present in Serbian market as the majority owner of Hemofarm from Vršac.
| 
| 
